Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-Dose Versus Multi-Dose Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection

NCT05719285 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT05719285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05719285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-Dose Versus Multi-Dose Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection
Lead sponsor
The Cleveland Clinic
Phase
Phase 4
Overall status
Completed
Start date
December 6, 2022
Completion date
June 8, 2023
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, overactive bladder syndrome, urge incontinence, urinary incontinence, urge